Fishman Jay A LTD Immunity Bio, Inc. Transaction History

Fishman Jay A LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$1.25 - $5.21 $182,000 - $758,576	145,600 New	145,600 $730,000
Q2 2023 Aug 15, 2023	BUY	$1.53 - $6.41 $247,860 - $1.04 Million	162,000 New	162,000 $450,000
Q1 2023 May 09, 2023	BUY	$1.35 - $4.78 $120,150 - $425,420	89,000 Added 386.96%	112,000 $203,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $56,549 - $88,010	13,000 Added 130.0%	23,000 $116,000
Q3 2022 Oct 26, 2022	BUY	$3.65 - $6.43 $36,500 - $64,300	10,000 New	10,000 $49,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.03B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.